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1. Evidence from kinetic studies in Brownian diffusion
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ABSTRACT The Smoluchowski theory describing aggregation in suspensions of spherical colloidal particles due to Brownian
diffusion-controlled two-body collisions, was used to obtain collision efficiencies, aB, for adenosine diphosphate
(ADP)-induced platelet aggregation in citrated platelet-rich plasma (PRP) from humans, dogs, and rabbits. For these diffusion
studies, PRP was stirred with 10 ,uM ADP for 0.5 s, then kept nonstirred at 370C for varying times before fixation; the percent
aggregation was computed from the decrease in particle concentration with time measured with a resistive particle counter.
Up to 20% of rabbit platelets formed microaggregates within 60 s of ADP addition to such nonstirred suspensions,
corresponding to mean aB values of - 0.9. However, human and dog platelets aggregated -10 times and 2-3 times faster
than rabbit platelets within the first 60 s of ADP addition, corresponding to a6B -8 and 2, respectively. These high aB (>> 1) for
human platelets were independent of initial platelet count and were equally observed with the calcium ionophore A23 187 as
activator. In about one-third of human, dog, or rabbit PRP, comparable and lower values of aB (<0.5) were obtained for a
slower second phase of aggregation seen for the nonstirred PRP over 60-300 s post ADP-addition. Platelet aggregability in
continually stirred PRP was distinct from that observed in Brownian diffusion (nonstirred) because comparable aggregation
was observed for all three species' stirred PRP, whereas >3-8 times more ADP is required to yield 50% of maximal rates of
aggregation for nonstirred than for stirred PRP. The above results point to the existence of long-range interactions mediating
platelet aggregation in Brownian diffusion-controlled platelet collisions which varies according to human > dog > rabbit
platelets. The roles for platelet pseudopods and adhesive sites in these long-range interactions are presented in part 2.
INTRODUCTION
Platelet adhesion and aggregation play a central role in
normal mammalian hemostasis and in the pathophysiol-
ogy of cardiovascular complications associated with life-
threatening thrombotic events (1-3). Platelets can collide
and stick to each other or to reactive surfaces under highly
variable flow regimes (3). It is therefore important to
understand the factors which control the movement of
platelets toward each other, other cells, and surfaces such
as the subendothelium, and which determine efficiencies
of adhesive events, under a variety of flow regimes.
Although physical factors such as rotation of red cells
which regulate platelet movements in flow have been
widely studied, we need to learn more about the effects of
platelet activation on platelet movements in suspension
and resulting adhesive events (3-5). Such an approach
was described for rabbit platelets aggregating in non-
stirred suspensions in response to the physiological activa-
tor, adenosine diphosphate (ADP) (6). The apparent
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efficiency of aggregation (aB) was obtained from a plot of
the inverse of platelet particle count as a function of time
after addition of the activator, based on a simple equation
first formulated by Smoluchowski (7). Thus, the rate of
particle aggregation for spherical particles of equal size
suspended in a medium and encountering one another
solely due to the influence of Brownian motion, has been
related to the efficiency, aB, as
(1.33 kT)dNt/dt = - . N2 aB,
where dNt/dt equals the change in particle number with
time; k, T, and ,u are the Boltzman constant, temperature,
and viscosity of the medium, respectively; and Nt equals
the particle concentration in suspension at time t.
This simple theory has been verified for suspensions of
spherical particles in the broad size range of 0.01-2-,um-
diam aggregating to form doublets, triplets, and multi-
plets up to six particles per aggregate (8-10). The
experimentally obtained aB values were generally <0.5-
0.8, i.e., the observed rate is generally <50-80% of that
predicted from simple diffusion, as observed, for example,
with slowly aggregating spherical polystyrene latex parti-
cles (10) in a similar size range as mammalian platelets
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(1). Indeed, Chang and Robertson (6) obtained similar aB
values of 0.4 ± 0.2 for rabbit platelets aggregating in
nonstirred suspensions in response to ADP. However, as
this has been the only report to date for platelets (6), we
wished to improve on the experimental techniques of
initially mixing the activator with platelets, of counting
the decay in particle number with time, and of using more
physiological conditions of temperature and pH. We also
extended these studies to include both human and dog
platelets, which have comparable sizes ( 11) and are about
twice the size of rabbit platelets (12). It was unexpectedly
observed that aB values determined for doublet and triplet
formation in Brownian diffusion were <1.0 for rabbit
platelets, -2 for dog platelets, and >> 1 for human plate-
lets. We evaluated the dependence of aB on platelet
number, time of observation, and ADP concentration, and
compared platelet aggregability in these nonstirred suspen-
sions with continuously stirred PRP. Our results point to
the existence of long-range interactions which effectively
enhance the initial rates of aggregation beyond that
predicted from simple considerations of diffusion of spher-
ical particles, with increasing magnitude for rabbit, dog,
and human platelets. The precise nature of these interac-
tions is explored in part 2.
METHODOLOGY
Preparation of platelet-rich plasma
Healthy men and women between the ages of 19 and 45 yr, free of
medication, gave blood with informed consent. Male and female rabbits
used were New Zealand albinos weighing 3-5 kg. In the human donors,
blood was collected from the antecubital vein by venipuncture. For
rabbit donors, a direct cut-out procedure from the isolated carotid artery
was performed using PEl90 or PE160 catheters after intramuscular
anesthetization (see Materials). Dog blood was obtained via (a) direct
percutaneous puncture of the saphenous vein of conscious dogs standing
quietly in a Pavlov sling, or (b) by catheterization of the isolated carotid
artery after intravenous anesthetization (see Materials). Unless other-
wise stated, blood was collected directly into 3.8% sodium citrate (1:9
vol/vol blood), and platelet-rich plasma (PRP) was prepared and
maintained at 370C, pH 7.4, for 30 min as previously reported (13),
before use for diluting original PRP to obtain lower platelet counts. In
two studies with rabbits (Table 1), blood and PRP were processed at
250C and the pH allowed to rise to 7.8. All studies with PRP were made
within 2-4 h of blood collection.
Aggregation kinetics and sensitivity
Platelet microaggregation (PA) was estimated, unless otherwise speci-
fied, from the percent decrease in the number of platelet particles as a
function of time (14, 15).
For diffusion-dependent studies, PRP (0.1 ml) was stirred in dispos-
able glass cuvettes (6.9 x 45 mm) using disposable metal stir bars
(6 x 1 mm) spun at 1,000 g at 37°C in an aggregometer, as previously
described (13). Adenosine diphosphate (ADP) was immediately added
with a Hamilton syringe (- 10 Mul) for a final concentration of 10 MM,
unless otherwise specified; stirred for <0.5 s; and immediately trans-
TABLE 1 Time-dependence of a. values for rabbit and
human donors
ab for
Time Rabbit (2)
Interval for Rabt()Humans (7)
Analysis at 250C at 370C 370C
s
0-10 NM1 NM 15.9 ± 12.3 (0.7 ± 0.3)"'
0-20 NM NM 6.8 ± 4.6 (0.7 ± 0.3)t
0-30 NM NM 7.5 ± 4.6 (0.8 ± 0.1)*
0-60 0.4 (0.3)' 0.9 (0.7)* 4.2 ± 1.6 (0.8 ± 0.1)
0-120 1.0 (0.7)* 0.6 (0.7)*
0-180 0.7t (0.7)* 0.8 (0.9)**
0-300 0.3 (0.6)* 0.5 (0.8)** 0.6 ± 0.4 (0.6)*
0-540 0.2 (0.7)* 0.3 (0.8)**
0-900 - 0.1 (0.6)*
*Average of values determined for each donor (±SD for human).
INM = not measurable, as PA < 5% (background) for <30 s.
"lr values for linear fit of data (typically shown in Fig. 2) are shown in
brackets, with significance indicated for p values <0.005**; <0.05*;
<0.2t; and <0.3'.
ferred to a temperature-regulated block heater acting as a large heat
sink maintained so that the sample temperature was 370C ± 0.1°C
(Temp-Block Module Heater, Canlab, Montreal, Canada; Block #2070,
49 mm high containing 7-mm-diam cylindrical holes with 78% of the
cuvette surrounded by the block). Samples were then fixed at different
times with 0.5 ml of 0.8% glutaraldehyde added directly to the cuvette,
previously shown to arrest changes in shape and aggregation in much <1
s (16). Aggregation due to 0.5 s mixing and fixation was confirmed to be
<5% (background) for each experiment reported here for both human
(H) and rabbit (R) studies. This was chosen because a latent time of - 1
s is required for onset of aggregation for both rabbit (below) and human
platelets (17).
Stir-induced aggregation (PA) studies were conducted with continu-
ous stirring after ADP addition and fixation at 3 and 10 s with
glutaraldehyde (16) as above. These stir-associated PA3 and PAlO
values were routinely determined just before all nonstir associated
studies of platelet aggregation.
The above studies were also repeated for human PRP using calcium
ionophore A23187 as the activator at 40 MM final concentration which
caused maximal stir-associated aggregation without inducing platelet
swelling seen at higher concentrations.
For counting platelets, 10 Ml of the fixed PRP suspension was
dispensed into 10 ml Hematall Isotonic Diluent, Azide Free (Fisher
Scientific Co., Montreal, Quebec, Canada). Decrease in particle concen-
tration with time was measured using an Elzone resistive particle
counter with a 48-am sensing aperture (Particle Data Inc., Elmhurst,
IL), as previously described (14, 15). The upper size discriminator was
set such that doublets and triplets formed in nonstirred suspensions were
detected as single particles (14, 15). Background counts were <200
particles per 100 Ml of diluted suspension counted in 10 s, whereas
particle counts were <7,000 per 100 Ml (no coincidence corrections
needed). The extent of platelet (particle) aggregation with time, % PAt,
was calculated from:
%PAt = (1 - Nt/No) 100%, (2)
where No, Nt are, respectively, the platelet particle counts at time zero
and t after activator addition (reproducibility <5%). The efficiency of
aggregation for platelets undergoing Brownian motion, aB, was calcu-
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lated from plots of No/Nt vs. t, using the following equation derived
from the integration of Eq. 1:
No/Nt = 1 + (1.33 kTNo/l,) aB * t. (3)
Particle counting and the number of platelets per aggregate were
occasionally evaluated by direct microscopy as previously reported using
glutaraldehyde-fixed PRP further diluted (four- to fivefold) with modi-
fied Tyrodes solution (16, 17). As previously reported (15), aggregation
(% PA) determined from total particle count using the electronic
particle counter was comparable to parallel measurements made with
the phase-contrast microscope (17); this was confirmed for both human
and rabbit PRP for 3 s-5 min post-ADP addition.
The sensitivity of ADP-induced platelet aggregation, reported as that
concentration yielding one half maximal rates of change ([ADP] '/2), was
determined as previously described for rates (PA3) and extent (PAIO)
of microaggregation (18). For diffusion-dependent studies, [ADP] /2
values were determined at post-ADP times ranging from 5-30 s.
Platelet shape change and
aggregation from light transmission
In the case of rabbit platelets, we determined [ADP] 1/2 values from
changes in light transmission of stirred suspensions for rates of shape
change (Vs) (19) and aggregation (Va) (16), as previously described.
For human platelets, we determined the ADP threshold concentration
yielding the second wave of stir-associated platelet aggregation (TA-2)
seen in turbidimetric measurements (20).
Mixing of activator with PRP for
diffusion-dependent studies
The flow characteristics of the diffusion-dependent studies made above
with <0.5 s stir of platelet-rich plasma with activator (ADP) addition
were evaluated as follows: plate-like crystals (hexagon -25 x 6 x 0.07
Mm), with identical time-dependent oscillations in light transmission
(swirl-effect) as for human or rabbit platelets (Fig. 8 in reference 4),
were stirred for 0.5 s as for platelets above. Visible flow-dependent swirl
completely stopped within 1.5 s of removal of the cuvette from the stir
device, with the half time for decay <1 s. In addition, the % PA for PRP
from rabbit and from a number of human donors was indeed <5% even
after 7 s of ADP addition (0.5 s stir and transfer to a 370C bath), ruling
out anomalously elevated % PA arising from any residual flow in the
suspension after the 0.5 s of stir for mixing the ADP activator in the
platelet suspension.
MATERIALS
Trisodium citrate (J. T. Baker Chemical Co., Phillipsburg, NJ) and
ADP (Sigma Chemical Co., St. Louis, MO) were prepared as previously
described (13). Intramedic R polyethylene catheters (PE190 and 160)
from Clay Adams Co. (Parsippany, NJ) were used in the direct cut-out
procedure. The anaesthetic used was a ketamine (35 mg/kg body
weight)-xylazine (5 mg/kg body weight) mixture (ketamine, Parke-
Davis Co., Canada, Inc., Scarborough, Ontario; xylazine, Haver-
Lockhart Bayvet Division, Miles Laboratories, Ltd., Rexdale, Ontario,
Canada). Glutaraldehyde (EM grade; Polysciences, Inc., Warrington,
PA) was freshly prepared from a sealed 8% stock solution diluted
10-fold with calcium-, magnesium-free Tyrodes solution at pH 7.4 (12).
Hematall isotonic diluent, Azide free (Fisher Scientific Co.) was used
for diluting samples for counting. The calcium ionophore A23187
(Calbiochem, Terochem Laboratories, Mississauga, Ontario), stored as
a solid at - 200C was freshly dissolved in dimethylsulfoxide (DMSO) to
make an 8-mM stock solution, and 5 Al was added to PRP to give a final
concentration of 40 ,uM.
RESULTS
Diffusion dependent (nonstirred)
ADP-induced aggregation
Time courses for platelet recruitment into microaggre-
gates (% PA) of human and rabbit PRP stirred with 10
,uM ADP for 0.5 s, and then left unstirred for Brownian-
diffusion-dependent aggregation are shown in Fig. 1.
Such curves obtained for many donors typically consisted
of a rapid primary phase of aggregation, followed either
by plateauing within 60 s or by a much slower secondary
phase. The time course for human platelets was unexpect-
edly faster than for rabbit platelets, with up to 50% of
human platelets recruited within the first 30-60 s of ADP
addition. Whereas all the rabbit donors exhibited at least
the rapid, primary phase (six donors examined), a small
number of human donors' platelets (7 of 41 donors) were
refractory to aggregation in nonstirred suspensions (10%).
The ratio of initial particle number (No) to that
changing as a function of time (Nt), was plotted as a
function of time for determination of aB values from the
slope of the best linear line of fit (see Eq. 3 in Methodol-
ogy). Typical plots are shown for data analyzed over the
first 30-60 s (Fig. 2) and over 5 min (Fig. 3) for both
human and rabbit donors. Although aB values for human
platelets were consistently >10 times higher than for
rabbit platelets when evaluated at the shorter time
% PA
T i me (s)
FIGURE 1 Kinetics of ADP-induced PA for nonstirred human (-) and
rabbit (0) PRP determined at 10 AM ADP. The human and rabbit
donor were chosen with PA3 and PA,lo values for stir conditions similar to
the average shown in Table 4.
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FIGURE 2 Determination of Brownian collision efficiency factor, aB, for
early time for human (0-30 s; *) vs. rabbit (0-60 s; 0) unstirred PRP.
r value for best line fit = 0.60 and 0.93 for rabbit and human,
respectively. Human aB = 10.88 when 60 s point (U) included; r value
for best line fit = 0.83.
intervals (Fig. 2; rapid, primary phase in Table 2), they
decreased to comparable aB values when analyzed over
longer time intervals (Fig. 3) or for the apparent slower
secondary phase represented by the 60-300 s interval
(Table 2).
We next studied the dynamics of aggregation of canine
platelets to evaluate the possible contributions of platelet
size to our observations, as canine platelets are about the
same size as human platelets (11), in contrast to rabbit
platelets which are about half the size (12). Initial rates of
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TABLE 2 a. and PAm,x for nonstirred rabbit, human,
and canine PRP*
Type of Donor Number aB PAmax
n/Nt %
Rabbit
Rapid, primary phase
(-60 s) 6/6 0.9 ± 0.4 13 (7-18)
Slower, secondary phase
(60-300 s) 2/6 0.3 ± 0.1 18 (15-21)
Human
Rapid, primary phase
(<60 s) 34/41 8.0 ± 5.01 30 (13-48)"
Slower, secondary phase
(60-300 s) 10/29 0.4 ± 0.2 34 (17-65)
Canine
Rapid, primary phase (< 60
s) 6/6 2.1 ± 0.7 24 (18-32)
Slower, secondary phase
(60-300 s) 3/6 0.7 ± 0.5 36 (29-46)
*10gM ADP used in all experiments.
W = total number of donors evaluated; note only 29/41 of the human
donors were evaluated beyond 60 s.
1Mean ± SD shown.
'Mean and range shown.
aggregation and aB values for the rapid primary phase
were intermediate between those seen for human and
rabbit platelets, with a slower secondary phase with a -
0.7 observed for canine platelets similar to that seen with
rabbit and human platelets (Table 2).
aB dependence on time
Because aB varied with time interval used for graphical
analyses of aggregation data (Figs. 2 and 3, and Table 2),
these were calculated for a series of time intervals for
rabbit and human PRP studies at 370C, as well as for
rabbit PRP evaluated at 250C for a more direct compari-
son with previously published data (6) (see Table 1). The
linear fit of the data for the change in 1/Nt with time,
predicted by Eq. 1, was most reproducible and significant
for time intervals between 0 and 60 s for both human and
rabbit platelets (correlation coefficients for linearity [r]
were generally -0.7-0.9, with highly significant r values
[probabilities p < 0.05]). This is the time interval chosen
to represent the rapid, primary phase in Table 2. Compa-
rably low values of aB for both rabbit and human platelets
are indeed observed whether analyzed for time intervals
of 0-5 min (Table 3), 60-300 s, or 0-15 min (Table 2).
Graphical analyses of the data in Table 1 for rabbit
platelets at 370C showed a linear or shallow exponential
decay in aB with increasing time intervals out to 900 s
(Fig. 4). A similar time plot for a typical human PRP
sample showed best fit lines steeply logarithmic or expo-
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FIGURE 3 Determination of Brownian collision efficiency factor, aB, for
0-300 s time course for human (U) vs. rabbit (0) unstirred PRP (same
donors as in Fig. 1). r values are 0.50 and 0.85, respectively, for human
and rabbit plots.
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TABLE 3 ADP sensitivity ([ADP1,,2) In human PRP
under stir and no stir
Ratio of
Aggregate [ADP] 1/2
conditions [ADP]1/2* [ADP]-TA2
No Stirt UM
PA5S10 9 ± 5 (5-17)" 3.2 (1.4-8.3)
PA20-30 6 ± 3 (2-10) 1.9 (1.1-2.9)
Stir
PA3 1.5 ± 0.5 (1-2) 0.4 (0.2-0.6)
PAIO 1.1 ± 0.4 (0.5-1.5) 0.3 (0.2-0.4)
*[ADP]max was 100 M; n = 10 donors.
t[ADP] I/2 determined separately at 5 and/or IO s and at 20 and/or 30 s
and then averaged.
I[ADP]-TA2 is the threshold concentration for turbidimetrically mea-
sured secondary aggregation, -3-5 gM ADP, determined for each
donor; the ratio [ADP] /2 for no stir to that for TA2 was obtained for
each donor and then averaged over all donors.
"Mean ± SD and range of values shown.
nential, with a possibility of a sharp logarithmic decay in
<60 s, followed by a more shallow decay analogous to that
observed for rabbit platelets (Fig. 4). Further evidence for
a steep time dependence of aB at the earliest activation
times for human platelets is seen from the data for human
platelets in Figs. 2 and 3 (intercepts >1) and in Table 1
(0-10 s time interval).
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FIGURE 4 Dependence of aB on the time interval chosen for analysis of
nonstir dependent collisions. Data taken from Table 3 and 4 for two
rabbit donors (R; 0) and for two typical human donors (H; *) for PRP
at 370C. For rabbit data, both linear (---) and exponential (-) best
fit lines are shown, with Y-intercept and significance (r; p values)
respectively 0.80 (0.92; p <0.01) and 0.90 (0.98; p < 0.005). For
human data both exponential (-) and logarithmic (- -) best fit lines
are shown, with Y-intercept and significance respectively 6.0 (0.82;
p < 0.025) and >14 (0.83;p < 0.025).
Intra-donor variations in human
platelet aB values
The large variations seen in aB measured for 10 ,uM
ADP-induced aggregation in nonstirred human platelet
suspension (Table 2) were also seen when aB values were
compared for the same donors on different occasions;
these aB values were however, consistently > 1. Thus, for
three donors tested on three to four different occasions,
the aB values, analyzed at the early time intervals (0-60
s), were found to be 6.9 ± 3.5 (range of 2.7-10.9), 3.7 +
1.6 (1.5-5.2), and 5.5 ± 3.4 (2.2-10.9).
Extent of nonstirred ADP-induced
aggregation
Table 2 shows that up to 20% of rabbit and up to 50% of
human and dog platelets are maximally recruited into
aggregates for ADP incubated in nonstirred platelet
suspensions (see PAma,, values). These aggregates con-
sisted of doublets and triplets: rabbit platelets observed
with a microscope between 60-900 s post-ADP addition
typically had 75-100% of all aggregated platelets as
doublets, whereas human and dog platelets examined over
10-300 s had 85-95% of aggregate platelets ip doublets
(two donors examined in each case).
aB dependence on platelet count
Given that Eq. 1 was derived for dilute suspensions of
freely diffusing particles and that the above determina-
tions of CB were made for platelet counts at -300-500 x
103 ,gL- 1 and given that rabbit platelets are about half the
volume of human platelets (12) so that about twice the
number per unit volume are required for similar volume
fractions, it was important to establish any effects of
platelet mass or volume fraction occupied by the platelets
in the PRP suspensions. When the initial platelet count
(No) was varied by two- to threefold over a range of
130-417 x 103 gl-1 for the same donor's PRP, aB values
measured at 0-10 s or 0-20 s varied by <17 ± 7% from
mean values (n = 7). For example, for a single donor's
PRP, where No was adjusted to 417, 230, and 131 (x 103
Al-1), aB values at 0-20 s were, respectively, 4.3, 5.8, and
3.4. These variations are well within the intradonor
reproducibility reported above, with no significant depen-
dence of aB on No (r = 0.05, p > 0.4; n = 7). Similar
results were obtained for aB values analyzed for longer
time intervals (0-60 s) for both human (r = 0.21) and
rabbit (r = 0.18) donors (p > 0.25).
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ADP-induced aggregation for stirred
platelets
Rabbit and canine platelets showed similar kinetics for
ADP-induced PA when evaluated for parallel PRP sam-
ples used above but stirred continuously (Table 4).
A similar time course for PA in response to 2-10 AM
ADP was seen for rabbit as previously reported for human
platelets (17), with an initial lag time of -1 s, an initial
linear rate of increase reflected in PA3 (PA at 3 s after
ADP addition) and maximal recruitment reflected in
PA1O. In fact, two rabbit donors were found to have
identical PA3 values (27% and 36%) as for two human
donors at similar platelet count (325,000 ul-'), with only
-10% more platelets maximally recruited for human than
for rabbit platelets; the aB differences shown in Table 2
persisted, however. In addition, rabbit platelets were of
comparable ADP sensitivity, if not more sensitive, than
human platelets for shape change (SC), stir-associated
microaggregation (PA3 and PA1o), or macroaggregation
(TA): [ADP]h/2being 0.25 ± 0.05 MiM for SC or PA and
0.7 ,M for TA for rabbit PRP studied for No at 300 or at
855 x 103 ul-1, compared with 0.35 ± 0.05 ,M for SC or
PA and 2.1 ± 0.3 AM for TA previously reported for
human platelets (16).
ADP sensitivity of
diffusion-dependent (nonstirred)
versus stir-associated human
platelet aggregation
The above similarities in stir-associated aggregation for
rabbit and human platelets activated by ADP stand in
contrast to the distinct aggregation dynamics observed for
the "no stir" conditions examined for one high ADP
concentration (10 MM) (Table 2). We therefore compared
the ADP log-dose response curves for aggregation of
human platelets in stirred vs. nonstirred suspensions.
Representative plots for the rate (PA3) and extent (PA1O)
of stir-associated platelet aggregation, as well as for PA at
20 s in nonstirred human PRP, are shown in Fig. 5. From
TABLE 4 Maximal rate and extent of ADP-induced,
stir-associated platelet aggregation for rabbit, human,
and canine donors*
Donor No PA3 PA1O
x 103Ml I % %
Rabbit (6)t 511 ± 1201 26 ± 5 71 ± 6
Human (32) 337 ± 61 45 ± 10 80 ± 6
Canine (6) 377 ± 41 49 ± 8 82 ± 5
*5-10MAM ADP used, yielding maximal PA.
tNo. of donors shown in brackets.
Mean ± SD shown for No, % PA3, % PAIO.
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FIGURE 5. ADP sensitivity for platelet aggregation in stirred (PA3:
-0--, PAI : - ) and nonstirred (PA20:--E0--) human platelet
suspensions. These curves represent the typical log-dose response curves
seen for the majority of human donors for stir (PA3 and PA1O) and
nonstir (PA20). * Represents PAma. values for all three parameters.
such plots, we derived the mean and range of values for
the ADP sensitivity, [ADP]1/2, corresponding to 50% of
maximal rates/extent of aggregation in human PRP
under stir and no-stir conditions, summarized in Table 3.
Maximal PA values were chosen for 100 MM ADP, rather
than for 10 MM ADP which yielded 80% of maximal
values for about half the donors. The [ADP] /2 values so
derived for platelet aggregation in nonstirred human PRP
were on average, -3-8 times greater than the [ADP]1/2
values measured for stirred suspensions for the initial rate
of platelet aggregation (represented by PA3), for the
maximal extent of platelet aggregation (represented by
PA1O), or for rate of turbidimetrically measured macroag-
gregation (VA) ([ADP]1/2= 1.7 ± 0.7 MM [1-3 ,M
range]). In addition, these [ADP] l/2 values for nonstirred
human PRP were on average 2-3 times greater than the
[ADP] required for stir-associated secondary aggregation
and release (TA2), in contrast to [ADP] /2 values for PA3
or PA1O in stirred suspension which were -2-3 times
lower than ADP-TA2 (see [ADP] 1/2: [ADP]-TA2 in
Table 3).
Calcium inonophore A23187
compared with ADP for platelet
aggregation in stirred versus
nonstirred suspensions
Given that an elevation in intracellular ionized calcium
represents a central pathway in receptor-mediated plate-
let activation (21), the results obtained for ADP as
activator were extended to a more direct, receptor-
independent, activation using the calcium ionophore
A23187 (21, 22). Using 40 ,M A23187, the initial rates
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TABLE 5 a. and PAm,x for nonstirred human PRP with
ADP vs. calcium lonophore A23187 as activators*
No stir Stir
Aggregation
conditions Number aB PA.. PA3 PAIo
n/N % % %
ADPt
Rapid, primary 4.0 ± 3.9" 28
phase (c60 s) 5/6 (1.2-10.9) (13-46) 37 8 72 ± 8
Slower, secondary 0.3 ± 0 26
phase (60-300 s) 3/6 (0.29-0.32) (17-32)
Calcium ionophore A231871
Rapid, primary 3.0 ± 1.4 25
phase-(<60 s) 6/6 (1.4-5) (15-46) 27 7 70 ± 6
Slower, secondary 0.1 ± 0 27
phase (60-300 s) 6/6 (0.1-0.2) (16-52)
*ADP vs. A23187 were both used as activators on the same donors'
PRP.
$10MM ADP used in all experiments.
140 MM calcium ionophore A23187 used in all experiments.
"Mean ± SD with range of values shown in brackets.
(PA3) and extent (PA1o) of aggregation with stir were,
respectively, very similar or identical to those observed
with 10 MM ADP conducted with PRP from the same
donors (right-hand side of Table 5). Comparable results
were also obtained for the Brownian collision efficiency
factors, aB, and associated % PA.. values, observed for
nonstirred human PRP activated with ADP or A23 187 in
parallel for the same donors, as summarized in Table 5. A
student's t-test using paired samples for aB values ob-
tained for calcium ionophore A23187 and ADP for each
donor over the five donors showing the rapid primary
phase for both activators showed no significant differences
(p < 0.4), with aB-A23187:aB-ADP ratios ranging
from 0.4 to 3.4.
DISCUSSION
We have obtained reasonable linear fits of data plotted as
the inverse of particle count (Nt-1) as a function of
diffusion time for ADP-induced aggregation of human,
canine, and rabbit platelets, as predicted by Smolu-
chowski (7) for spherical particles (Eq. 1) and recently
reported for aggregating rabbit platelets by Chang and
Robertson (6). We have obtained apparent aB values from
the slopes of these lines, using Eq. 1. Unusually large
values of aB (> 1) were obtained for human platelets
evaluated within 1-2 min of ADP activation in suspen-
sions stirred for <0.5 s, in contrast to intermediate values
for canine platelets, and lowest values for rabbit platelets
in the range of 0-0.7 as previously reported for rabbit
platelets (6) and for colloidal suspensions (8-10). Chang
and Robertson (1976) used this approach with rabbit
platelets activated by slow mixing of ADP with PRP
using a spatula over 10 s, at 250C and pH 7.7, with the
first measurement of aggregation then made at 60 s. They
found % PA values for six rabbits measured at 1, 5, and 10
min post-ADP addition for nonstirred suspensions corre-
sponding to mean aB values of 0.4 ± 0.2. We obtained
similar results for rabbit PRP using more efficient mixing
(0.5 s of stir), whether determined at 250C, pH 7.7 or at
370C, pH 7.4. Thus, analyses of our data in Tables 1 and 2
for post-ADP times of 1, 5, and 10 min gave aB in the
range of 0-0.3. However, we found that % PA measured
within the first 1-2 min of ADP addition to rabbit PRP
stirred only for 0.5 s was up to four times faster than that
reported by Chang and Robertson, for 370C or 250C
preparations. This more rapid aggregation corresponds to
calculated aB values of 0.9-1.0 (Tables 1 and 2).
The large aB values observed for human platelets
activated with ADP were equally seen when the receptor-
independent activator, calcium ionophore A23187, was
used, suggesting that these results can be expected with a
wide range of competent activators. Furthermore, these
aB values cannot be attributed to any anomalies in platelet
concentration nor in size of aggregates formed. Thus, the
calculations of anomalously high aB > 1 for human
platelets did not appear to be affected by the initial
particle concentration, No, which was in the same range
as previously reported for rabbit studies (6) and similar to
studies with latex particles (<7 x 103 Ml-' [10]). In
addition, the microaggregates formed in the nonstirred
human, dog, and rabbit platelet suspensions consisted
almost entirely of doublets (>75%), with the balance as
triplets, as similarly reported by Chang and Robertson
(6).
The abnormally high aB values observed for nonstirred
PRP for human donors within the first 30-60 s of 10 ,uM
ADP addition (Table 2), do not appear to arise from the
following possible artifacts: (a) time-dependent removal
of platelets due to adhesion and aggregation onto surfaces
of cuvettes and stir bars which was negligible for both
species (<2%); (b) gravitational settling in nonstirred
PRP over the times evaluated which was insignificant
(<2%) as previously reported for rabbit PRP (6); and (c)
thermal convective flow contributions which would be
expected to yield more anomalous aB values for rabbit
platelets which are on average about half the size of
human platelets (12), but the reverse was observed;
moreover, very similar results were obtained for rabbit
PRP incubated in the 370C dry bath or simply in a plastic
container left at ambient temperature (250C) (see Table
1).
Because human platelets exhibited very similar kinetics
(Table 4) and sensitivity for ADP-induced aggregation in
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stirred PRP as for rabbit platelets, it was rather unex-
pected to find >10 times higher aB values than normally
observed for rabbit platelets (6) or "sticky" colloidal
particles (8-10). Similarly, the 2 fourfold higher values
of aB for human over that of canine platelets was equally
unexpected because identical aggregation kinetics was
observed for continuously stirred suspensions of PRP
from either species (Table 4). Moreover, s20-30%, on
average, of rabbit, canine, or human platelets were
efficiently recruited into aggregates with optimal aB
values in a primary phase in diffusion-dependent aggrega-
tion, in contrast to ,70-80% maximal and rapid recruit-
ment for all three species in continuously stirred PRP
suspensions (Table 4 vs. 2). Thus, it appears that human
or canine PRP contains about one-third of anomalously
active platelets (aB >> 1.0); up to another one-third with
intermediate reactivity closer to that seen for rabbit
platelets (aB = 0.4-0.7 in Table 2); and the balance with
an apparent aB = 0. Rabbit platelets appear to be mostly
(>80%) unable to aggregate under nonstirring conditions
(a 0O). These low aB values clearly cannot be ascribed to
decreasing platelet counts with time (Nt), as up to two to
threefold decreases in No did not seem to affect aB
measured over 10-60 s. Although the existence of platelet
subpopulations with distinct reactivities to ADP have
been previously reported for stir-associated aggregation,
these differences were only about twofold for the largest
vs. smallest human platelet populations (23, 24). If, in
fact, aB values for platelets aggregating in unstirred
suspensions are initially high for all platelets, then a
time-dependent refractoriness could explain a decay in aB
with time; this does not, however, appear to be a signifi-
cant factor, particularly at early times (discussed in part
2).
The sensitivity of human platelets to ADP-induced
aggregation in nonstirred PRP was unusually low com-
pared with that found for parallel studies of stir-
associated aggregation (Fig. 5; Table 3). Thus, for [ADP]
of 1 ,uM, sufficient to cause from 50-100% of maximal
rates (PA3) and extent (PA1O) of platelet recruitment into
microaggregates for stirred platelet suspensions, aB in
most donors approached zero even at the early times
evaluated (5-30 s post-ADP addition). Thus, -3-8 times
higher [ADP] is required to cause 50% of maximal initial
rate of recruitment for nonstirred human PRP than that
required for stir-induced aggregation. In addition, these
[ADP] 1/2 values were -2-3 times above the concentration
of ADP required to initiate stir-associated secondary
aggregation and release reactions (20) (Table 3). How-
ever, neither ADP nor calcium ionophore A23 187, which
also yielded comparably large aB values at high concentra-
tions (Table 5), are expected to cause significant granule
release in PRP unless macroaggregation first occurs
(20, 25); in fact, the largest aggregates in the nonstirred
studies are triplets. It is clear, however, that maximal
activation with high activator concentration is required to
drive platelets to aggregate efficiently in Brownian diffu-
sion. The effects of inhibitors will be explored in part 2.
The anomalously fast and efficient recruitment of
platelets after ADP activation in nonstir conditions at
early times point to the existence of long-range interac-
tions, especially for human and canine platelets. More
recent and generalized theoretical considerations pre-
sented in part 2 predict that the experimentally measured
aB values can be > 1, as we report for human and canine
platelets, if the actual capture frequency for aggregation
is enhanced by electrostatic attractive interactions or by
long-range interactions mediated, for example, by long
bridging structures such as filaments extending from the
aggregating particles (26). Although models for long-
range interactions in platelets could be based on the
demonstrated chemotactic behavior of platelets mediated,
for example, by collagen-associated chemotaxins (27), or
on specific interactions of fibrin polymers with activated
platelet membranes (28), the most likely model under
investigation is focused on the contributions of pseudo-
pods extending from activated platelets (1, 17, 29) (see
part 2). Such long-range interactions will likely be most
significant in (patho) physiology of hemostasis and throm-
bosis occurring in areas of reduced flow, including ex-
travascular areas, bifurcations, and areas of thrombotic
depositions (2, 3).
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